Anixa Biosciences (ANIX) Current Assets (2010 - 2026)
Anixa Biosciences (ANIX) reported Current Assets of $14.91 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), down 14.5% from $17.45 million a year earlier but up 1.5% from the prior quarter.
Powered by 
Analysis
Anixa Biosciences (ANIX) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), Anixa Biosciences posted Current Assets of $15.89 million, down 25.6% from FY2024.
- Current Assets has declined for four consecutive fiscal years, though with a five-year compound annual growth rate of 11.1% (FY2020 to FY2025).
- By fiscal year, Current Assets came in at $21.36 million in FY2024 (-15.8%), $25.36 million in FY2023 (-16.0%), $30.2 million in FY2022 (-16.1%) and $36 million in FY2021 (+284.3%).
- Five-year quarterly Current Assets spans a low of $14.69 million in fiscal Q2 2026 and a high of $36 million in fiscal Q4 2021.
- The high point for year-over-year Current Assets in five years was fiscal Q4 2021 (growth of 284.3%); the low point was fiscal Q2 2025 (a decline of 30.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,140.21 Bn | 1,108.80 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 632.33 Bn | 552.19 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 500.02 Bn | 473.13 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 355.31 Bn | 309.69 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 300.67 Bn | 264.66 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 263.56 Bn | 237.25 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 237.81 Bn | 193.20 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 194.42 Bn | 168.61 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 171.28 Bn | 117.93 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Anixa Biosciences | 99.13 Mn | 85.26 Mn | - | 14.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 14.91 Mn |
| Apr 30, 2026 | 14.69 Mn |
| Oct 31, 2025 | 15.89 Mn |
| Jul 31, 2025 | 17.45 Mn |
| Apr 30, 2025 | 16.77 Mn |
| Jan 31, 2025 | 18.69 Mn |
| Oct 31, 2024 | 21.36 Mn |
| Jul 31, 2024 | 22.67 Mn |
| Apr 30, 2024 | 24.21 Mn |
| Jan 31, 2024 | 25.22 Mn |
| Oct 31, 2023 | 25.36 Mn |
| Jul 31, 2023 | 26.40 Mn |
| Apr 30, 2023 | 27.41 Mn |
| Jan 31, 2023 | 28.11 Mn |
| Oct 31, 2022 | 30.20 Mn |
| Jul 31, 2022 | 32.34 Mn |
| Apr 30, 2022 | 32.56 Mn |
| Jan 31, 2022 | 34.99 Mn |
| Oct 31, 2021 | 36.00 Mn |
| Jul 31, 2021 | 37.05 Mn |
API Access
Anixa Biosciences Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();